Published Nov 20, 2024

The Secret to Reversing Chronic Pain & Aging Before It’s Too Late | Dr. Adeel Khan

Dr. Adeel Khan delves into the transformative realm of regenerative medicine with host Mark Hyman, highlighting cutting-edge therapies like stem cells, exosomes, and gene therapy that could reverse chronic pain, aging, and autoimmune diseases, while envisioning a future where these innovations revolutionize healthcare.
Episode Highlights
The Doctor's Farmacy with Mark Hyman, M.D. logo

Popular Clips

Questions from this episode

Episode Highlights

  • Emerging Tech

    Emerging technologies in regenerative medicine are reshaping the future of healthcare. highlights the potential of automated cell manufacturing, which could significantly reduce costs and make treatments more accessible 1. He believes that social media will play a crucial role in accelerating the adoption of these innovations by increasing public awareness and demand 2. The advancements in stem cell research, particularly the discovery of musels, offer promising results for treating various degenerative conditions 3.

    Patients have the right to have all their options explored, and especially options that are safe and can be just as effective as surgery.

    ---

    These developments suggest a future where regenerative medicine becomes a mainstream option for patients seeking alternatives to traditional treatments.

       

    Adoption Barriers

    Despite the promising advancements, regenerative medicine faces significant barriers to widespread adoption. points out that political and financial challenges in the U.S. hinder the availability of treatments that are already accessible in countries like Japan 4. Safety remains a top priority, with exosomes and mesenchymal stem cells showing strong safety profiles, yet they are underutilized as alternatives to conventional treatments 5.

    Safety is always number one. Exosomes are so safe.

    ---

    Overcoming these challenges requires increased funding and awareness to ensure patients have access to these innovative therapies.

Related Episodes